Biocartis Group NV
XBRU:BCART

Watchlist Manager
Biocartis Group NV Logo
Biocartis Group NV
XBRU:BCART
Watchlist
Price: 0.29 EUR Market Closed
Market Cap: 27.2m EUR
Have any thoughts about
Biocartis Group NV?
Write Note

Wall Street
Price Targets

BCART Price Targets Summary
Biocartis Group NV

There are no price targets for BCART.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Biocartis Group NV Competitors:
Price Targets
IPD
ImpediMed Ltd
169% Upside
ZIMV
ZimVie Inc
47% Upside
LMAT
LeMaitre Vascular Inc
6% Downside
002223
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
35% Upside
BDX
Becton Dickinson and Co
27% Upside
605186
Shanghai General Healthy Information and Technology Co Ltd
13% Upside
SRDX
Surmodics Inc
12% Upside
FNA
Paragon 28 Inc
46% Upside

Revenue
Forecast

Revenue Estimate
Biocartis Group NV

For the last 8 years the compound annual growth rate for Biocartis Group NV's revenue is 27%. The projected CAGR for the next 3 years is 21%.

27%
Past Growth
21%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biocartis Group NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Biocartis Group NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCART's stock price target?
Not Available

BCART doesn't have any price targets made by Wall Street professionals.

What is Biocartis Group NV's Revenue forecast?
Projected CAGR
21%

For the last 8 years the compound annual growth rate for Biocartis Group NV's revenue is 27%. The projected CAGR for the next 3 years is 21%.

Back to Top